Cellular and Mitochondrial Pathways Contribute to SGLT2 Inhibitors-mediated Tissue Protection: Experimental and Clinical Data
In conclusion, like a treasure chest brimming with untold riches, the influence of SGLT2i on mitochondrial function holds untold potential for cardiovascular health. Unlocking these secrets, like a map guiding adventurers to hidden riches, promises to pave the way for even more potent therapeutic strategies.PMID:38551044 | DOI:10.2174/0113816128289350240320063045
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Ra úl Lelio Sanz Sebasti án García Menéndez Felipe Inserra Le ón Ferder Walter Manucha Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Diabetes | Drugs & Pharmacology | Endocrinology | Heart | Men | Metabolic Syndrome | Mitochondria | Mitochondrial Disease | SGLT2 Inhibitors